EXCHANGE AGREEMENTExchange Agreement • July 19th, 2023 • Kiromic Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 19th, 2023 Company Industry JurisdictionThis Exchange Agreement (this “Agreement”), dated as of July 18, 2023, is made by and between Kiromic BioPharma, Inc., a Delaware corporation (the “Company”), and the holder of the Exchange Securities as set forth below (the “Holder”).
EXCHANGE AGREEMENTExchange Agreement • March 31st, 2023 • Kiromic Biopharma, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 31st, 2023 Company Industry JurisdictionThis Exchange Agreement (this “Agreement”), dated as of March 28, 2023, is made by and between Kiromic BioPharma, Inc., a Delaware corporation (the “Company”), and the holder of the Exchange Securities as set forth below (the “Holder”).